Market Research Logo

3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

The patent landscape related to 3D cell technologies is very open, involving important academic applicants as well as small companies. It includes over 2,500 patent families and involves over 1,000 patent applicants. Cell culture in two dimensions is widely used for various applications, from fundamental research to biomedical applications. However, this type of culture doesn’t reproduce the natural physiological microenvironment of a cell or an organ. Going from two to three dimensions allows the culture conditions to get closer to the true in vivo environment of the cells and 3D cell culture models are becoming more and more popular. In 2015, the 3D cell culture market was valued at $725 million and is estimated to grow at a CAGR of 30.6% between 2015 and 2020 (source : Meticulous Research, May 2016). Surprisingly, while many companies provide products dedicated to 3D cell culture on the market, these companies don’t appear among the main patent applicants in the IP side of the domain. In fact, the Top-10 of the main assignees owns less than 10% of the whole patent families and no patent assignee is taking over the 3D cell culture domain. This finding indicates that the IP landscape and market for 3D cell culture are currently structuring and should both evolve in the coming years. The IP landscape related to 3D cell culture is dominated by American and Asian applicants. As a consequence, the USA, China and Japan as well as Korea to a lesser extent represent the main countries of filings. However, Europe seems to represent a new interest for patent assignees and patent publication level in Europe is close to the publication level observed in China.


INTRODUCTION
Authors
Key Features of the Report
Objectives of the Report
Scope of the Report
Terminology for Patent Analysis
Methodology
Search Strategy
Search Strategy for Technical Segmentation
Main Assignees Mentioned
Technology Overview
EXECUTIVE SUMMARY
IP OVERVIEW
Time Evolution of Patent Publications
Countries of Patent Filings
Time Evolution by Country of Filing
Current Legal Status of Patents in the Portfolio
Ranking of Main Patent Applicants
Time Evolution for Main Patent Applicants
Countries of Filings for Main Patent Applicants
Mapping of Main Current IP Holders
Mapping of Main Current IP Applicants
Main IPC Classes
Time Evolution by IPC
Matrix Main Priority Countries / Main IPC
Matrix Main Applicants / Main IPC
Summary of Applicant’s Patent Portfolio
Leadership of Patent Applicants
Degree of Specialization in
D Cell Culture Technologies
Citations Analysis
Strength Index of Patent Portfolios
IP Blocking Potential of Patent Applicants
Patent Applicants IP Network
Key Patent Families
Granted Patents Near Expiration
TECHNICAL ISSUES
Technical Segmentation
Time Evolution of Patent Publications by Culture System
Time Evolution of Patent Publications by Application
Current Legal Status of Patents by Technical Segment
Countries of Patent Filings by Technical Segment
MAIN PATENT LITIGATIONS
University of Pittsburg vs Hedrick, Benhaim, Lorenz & Zhu
University of Pittsburg vs Cellerix (TiGenix)
SkinMedica vs Histogen & G.K. Naughton
MIT and Children’s Medical Center Corporation vs Shire, Shire Pharmaceutical and SRM
Potential Future Plaintiffs
KEY PLAYERS
A*STAR
Columbia University
Corning
DICP
KIMM
MIT
NASA
Osaka University
Pluristem
Seoul National University R&DB Foundation
Third Military Medical University
University of California
University of Michigan
Zhejiang University
CONCLUSIONS
ANNEX
CUSTOMER SATISFACTION SURVEY

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report